Ryan J. Mattison

1.9k citations

58 papers · 518 indexed · h-index 12

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 36
- Acute Myeloid Leukemia Research 24
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 5
Genetics 26
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Chronic Lymphocytic Leukemia Research 9

Co-authors: Roger Luo Joseph J. Kaberlein Shyam Prabhakar Fuhong HeJun WuMichael J. Thirman Shuangli Mi Hongkai Ji
Journals: Blood (20 papers)Journal of Clinical Oncology (5 papers)Leukemia Research (2 papers)Blood Advances (2 papers)HemaSphere (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Ryan J. Mattison

55 papers receiving 515 citations

Peers

Countries citing papers authored by Ryan J. Mattison

Since Specialization

Citations

This map shows the geographic impact of Ryan J. Mattison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan J. Mattison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan J. Mattison more than expected).

Fields of papers citing papers by Ryan J. Mattison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan J. Mattison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan J. Mattison. The network helps show where Ryan J. Mattison may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan J. Mattison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan J. Mattison Line = papers co-authored together Ryan J. Mattison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL) Transplantation and Cellular Therapy ·Armin Ghobadi, Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel, E. Coen Beuyery, Rawan Faramand, Ryan J. Mattison, Michael P. Rettig, Kenneth Jacobs, Ouiam Bakkacha, John Muth, Josiah Sleppy, Josiah Sleppy, 泰行清田, A. Michael Johnston, Matthew Cooper, Jan Davidson‐Moncada, John F. DiPersio	2024	1
2	Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia JCO Precision Oncology ·J.M. Munoz, R. Geurs, Mandar Pitale, Daming Chen, Matthew Brunner, Michael J. Fallon, Supak Tontisirin, Katarina Tokić, Víctor Mira Juan, Navin Riihle, Ryan J. Mattison, Zhubin Gahvari, Aric C. Hall, Kalyan Nadiminti, João Serafim Tusi da Silveira, Jane E. Churpek	2024	1
3	Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T Magnetic Resonance in Medicine ·Alvin J. Henry, Julia Velikina, Lu Mao, Ruiyang Zhao, Qing Yuan, Mounes Aliyari Ghasabeh, Stefan Ruschke, Dimitrios C. Karampinos, David Harris, Ryan J. Mattison, Michael Jeng, Iván Pedrosa, Ihab R. Kamel, Shreyas Vasanawala, Takeshi Yokoo, Scott B. Reeder, Diego Hernando	2024	0
4	Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients – A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia Radiotherapy and Oncology ·Grace C. Blitzer, Charu Yadav, R Venkataramman, Robert B. France, Jayeeta Giri, Andrea Pennati, Ross O. Meyers, Amber M. Bates, Kwangok P. Nickel, Gracia Christy Tooy, Zachary S. Morris, Ryan J. Mattison, Kimberly A. McDowell, Charlotte Schultz Thers, Richard J. Chappell, M. Ghasoub, Nicole Rogus‐Pulia, Jacques Galipeau, Randall J. Kimple	2024	4
5	Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee Blood Advances ·Michael Byrne, Ryan J. Mattison, Rachel S. Bercovitz, Richard Lottenberg, Suely Meireles Rezende, Roy L. Silverstein, Deirdra R. Terrell, Н. М. Березина, E Li, Catherine M. Bollard, Sandra L. Haberichter, Jennifer Holter‐Chakrabarty, Menaka Pai, Matthew C. Cheung, Adam Cuker, Matthew D. Seftel, Benjamin Djulbegović	2023	1
6	Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma–stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia Cytotherapy ·Grace C. Blitzer, M. Ghasoub, (unknown), Iip Apip, Robert B. France, Ross O. Meyers, Kimberly A. McDowell, Kwangok P. Nickel, Ryan J. Mattison, Gracia Christy Tooy, Richard J. Chappell, Nicole Rogus‐Pulia, Jacques Galipeau, Randall J. Kimple	2023	16
7	Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemia Leukemia Research ·山中寛惠, J.M. Munoz, Fauzia Osman, R. Geurs, Daming Chen, Долгун, João Serafim Tusi da Silveira, Ryan J. Mattison	2023	2
8	Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer Cytotherapy ·Grace C. Blitzer, Nicole Rogus‐Pulia, Ryan J. Mattison, Tomy Varghese, Robert B. France, Richard J. Chappell, Jacques Galipeau, Kimberly A. McDowell, Ross O. Meyers, M. Ghasoub, Randall J. Kimple	2022	16
9	Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI Radiology ·Diego Hernando, Ruiyang Zhao, Qing Yuan, Mounes Aliyari Ghasabeh, Stefan Ruschke, Werner Mühlfelder, Dimitrios C. Karampinos, Lu Mao, David Harris, Ryan J. Mattison, Michael Jeng, Iván Pedrosa, Ihab R. Kamel, Shreyas Vasanawala, Takeshi Yokoo, Scott B. Reeder	2022	26
10	A Phase I Trial of Talazoparib in Patients with Advanced Hematologic Malignancies SHILAP Revista de lepidopterología ·Ajay K. Gopal, Rakesh Popat, Ryan J. Mattison, Tobias Menne, Adrian Bloor, Terry J. Gaymes, Asim Khwaja, Mark Juckett, Ying Chen, Matthew J. Cotter, Ghulam J. Mufti	2021	6
11	Safety and Tolerability of Fedratinib (FEDR), an Oral Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate- or High-Risk Myelofibrosis (MF) Previously Treated with Ruxolitinib (RUX): Results from the Phase 3b FREEDOM Trial Blood ·Vikas Gupta, Abdulraheem Yacoub, Srđan Verstovšek, Ruben A. Mesa, Claire Harrison, Giovanni Barosi, Jean‐Jacques Kiladjian, H. Joachim Deeg, Salman Fazal, Lynda Foltz, Ryan J. Mattison, Carole B. Miller, Robin Tholin, LoisA. Abbott, Christopher Hernandez, Tianhua Wang, Moshe Talpaz	2021	8
12	Muscle relaxants as adjunctive analgesics in the perioperative setting: A review of the literature Journal of Perioperative Practice ·Ryan J. Mattison, Jun-Ha Shin, Liuting Lu, Michael A. Veronin	2021	2
13	Reducing patient wait time on an inpatient hematology and transplant unit. Journal of Clinical Oncology ·Ryan J. Mattison, Chul-Yung Cha, Dietrich Jesch, D. Kayton, Sherif Soliman, R. W. TOWNE, Z. H. Liu, Damiano Guarnieri, Thibaut Alzieu, G.-J. Kim, Andrew Brown, P. Bauwens, G Green, Poliméricas Ocas, Mark Juckett, Julius Atamenwan, Ruth O’Regan, Novela Aditiya	2016	3
14	A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia Investigational New Drugs ·Olatoyosi Odenike, Anna B. Halpern, Lucy A. Godley, Jozef Madžo, Theodore Karrison, Margaret Green, Noreen Fulton, Ryan J. Mattison, Karen Yee, Rahma Ibrahim Abdullah Daghriri, ML Male, Gregory Malnassy, Richard A. Larson, Mark J. Ratain, Wendy Stock	2014	10
15	A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome Leukemia & lymphoma ·Ryan J. Mattison, Tavip Kharisma Putra, Patrick J. Flynn, Alvaro Moreno‐Aspitia, Charles Erlichman, Betsy LaPlant, Mark Juckett	2014	9
16	Regulation of MEIS1 by distal enhancer elements in acute leukemia Leukemia ·John M DeWitt, 純山崎, Lena Lohjelm, Bingjie Li, Joseph J. Kaberlein, Marion Finkbeiner, J. B. Rajbhandaray DiBins, Roger Luo, Jun Ni, Fuhong He, Jun Wu, Ryan J. Mattison, Jing Zhou, Hutchinson Jm, Shyam Prabhakar, Marcelo A. Nóbrega, Michael J. Thirman	2013	15
17	New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemia Current Opinion in Hematology ·Ryan J. Mattison, Selina M. Luger, Hillard M. Lazarus	2013	9
18	Weekly Temsirolimus and Bortezomib For Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma: A Wisconsin Oncology Network Phase II Study Blood ·Timothy S. Fenske, KyungMann Kim, Chong Zhang, John P. Farnen, Adedayo A. Onitilo, Jules H. Blank, Harish G. Ahuja, Raymond E. Thomas, Rubina Qamar, Patrick J. Mansky, Anne M. Traynor, Ryan J. Mattison, Brad S. Kahl	2013	1
19	Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia Current Opinion in Oncology ·Ryan J. Mattison, Richard A. Larson	2009	6
20	Approaches to treatment for acute lymphoblastic leukemia in adolescents and young adults Current Hematologic Malignancy Reports ·Ryan J. Mattison, Wendy Stock	2008	2

About Ryan J. Mattison

Ryan J. Mattison is a scholar working on Hematology, Genetics, Emergency Medicine, Oncology and Otorhinolaryngology, having authored 58 papers that have together received 518 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (9 papers), Acute Lymphoblastic Leukemia research (7 papers), Hematological disorders and diagnostics (6 papers), Multiple Myeloma Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hematology (273 citations), Genetics (159 citations), Otorhinolaryngology (19 citations), Oncology (111 citations) and Molecular Biology (238 citations). Ryan J. Mattison has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Roger Luo, Joseph J. Kaberlein, Shyam Prabhakar, Fuhong He, Jun Wu, Michael J. Thirman, Shuangli Mi, Hongkai Ji, George Y. Wu and Qian-Fei Wang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Blood Advances and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact